EXMceuticals Inc. (the "Company" or "EXM") announced that it has entered into a letter of intent ("LOI") with Econnabis SAS, an operating subsidiary of Plena Global Holdings Inc. ("Plena Global"), a large-scale producer and supplier of medical grade cannabis ingredients, to supply EXM's proposed Portugal refinery with up to 200 kg of GMP compliant THC Distillate. This agreement continues EXM's focus on being the gateway to the European market for the existing legal cannabis industry. Over the past 60 days, Management has been focused on utilizing its existing Portugal operations as an expert powerhouse to the EU market. While many companies look to expand overseas into the EU marketplace, EXM's operational and business development footprint will be in a strategic position to build shareholder and stakeholder value across multiple verticals and a wide variety of cannabinoid formulations. Plena Global and its suppliers adhere to all regulatory requirements and follow both Good Agricultural and Collection Practices ("GACP") and European Good Manufacturing Practices ("EU-GMP") standards and procedures. Plena Global and its suppliers have rigorous quality and compliance controls to ensure secure shipment of products. Furthermore, Plena Global's access to leading a world-class collection of plant genetics will support EXM client's requirements for specific strains.